Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 124.33 | = | 494.24 | ÷ | 3.98 | 3.98 | = | 580 | ÷ | 145,900,000 | |
| Feb 11, 2020 | 44.17 | = | 296.00 | ÷ | 6.70 | 6.70 | = | 985 | ÷ | 147,000,000 | |
| Feb 12, 2019 | 48.64 | = | 292.20 | ÷ | 6.01 | 6.01 | = | 883 | ÷ | 147,000,000 | |
| Feb 13, 2018 | 53.47 | = | 220.44 | ÷ | 4.12 | 4.12 | = | 606 | ÷ | 147,000,000 | |
| Feb 14, 2017 | 40.99 | = | 164.46 | ÷ | 4.01 | 4.01 | = | 587 | ÷ | 146,300,000 | |
| Mar 2, 2016 | 37.71 | = | 157.20 | ÷ | 4.17 | 4.17 | = | 613 | ÷ | 147,000,000 | |
| Feb 18, 2015 | 55.49 | = | 198.62 | ÷ | 3.58 | 3.58 | = | 515 | ÷ | 143,800,000 | |
| Feb 18, 2014 | 162.89 | = | 170.40 | ÷ | 1.05 | 1.05 | = | 134 | ÷ | 128,200,000 | |
| Feb 15, 2013 | 30.11 | = | 48.73 | ÷ | 1.62 | 1.62 | = | 201 | ÷ | 124,040,754 | |
| Feb 24, 2012 | 31.41 | = | 51.22 | ÷ | 1.63 | 1.63 | = | 199 | ÷ | 122,327,021 | |
| Feb 28, 2011 | 41.85 | = | 69.40 | ÷ | 1.66 | 1.66 | = | 212 | ÷ | 127,626,004 | |
| Feb 26, 2010 | 34.79 | = | 36.32 | ÷ | 1.04 | 1.04 | = | 126 | ÷ | 120,298,934 | |
| Feb 26, 2009 | 48.40 | = | 32.16 | ÷ | 0.66 | 0.66 | = | 80 | ÷ | 121,077,875 | |
| Feb 26, 2008 | — | = | 37.23 | ÷ | -2.71 | -2.71 | = | -301 | ÷ | 111,090,078 | |
| Feb 28, 2007 | 53.36 | = | 16.80 | ÷ | 0.31 | 0.31 | = | 38 | ÷ | 120,098,536 | |
| Mar 6, 2006 | — | = | 12.79 | ÷ | -0.26 | -0.26 | = | -21 | ÷ | 82,538,624 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Illumina Inc. Annual Report.
The Price to Operating Profit (P/OP) ratio exhibits significant volatility over the analyzed period, characterized by extreme peaks and intervals of relative stabilization. While the share price demonstrates a consistent long-term upward trajectory, the valuation relative to operating profit reveals periods of substantial divergence, suggesting fluctuating market expectations regarding future growth.
- Valuation Spikes and Divergence
- Two primary anomalies in the P/OP ratio are observed in 2014 and 2021. In 2014, the ratio peaked at 162.89, driven by a sharp increase in share price to 170.40 alongside a decrease in operating profit per share to 1.05. A similar pattern emerged in 2021, where the P/OP ratio climbed to 124.33 as the share price reached a historical high of 494.24 while operating profit per share declined to 3.98. These spikes indicate periods where market valuation significantly decoupled from current operating performance.
- Operating Profitability Trends
- Operating profit per share was inconsistent during the early years, recording negative values in 2006 and 2008. However, from 2009 to 2020, a general growth trend is evident, with profit per share rising from 0.66 to a peak of 6.70. This growth phase provided a fundamental basis for the increase in share price, although the pace of price appreciation often outstripped profit growth.
- Periods of Relative Valuation Stability
- Between 2012 and 2013, the P/OP ratio remained relatively low and stable, ranging between 30.11 and 31.41. A more prolonged period of moderate stability occurred from 2015 to 2020, during which the ratio generally fluctuated between 37.71 and 55.49. During this window, the expansion of the share price was more closely aligned with the steady increase in operating profit per share.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 124.33 | 16.32 | 14.96 | 36.91 | 19.38 | 14.82 | 22.81 | 19.16 |
| Feb 11, 2020 | 44.17 | 10.82 | 13.84 | 34.47 | 20.66 | 19.01 | 26.84 | 51.98 |
| Feb 12, 2019 | 48.64 | 18.35 | 11.46 | 23.18 | 10.15 | 17.53 | 27.33 | 74.57 |
| Feb 13, 2018 | 53.47 | 19.63 | 12.71 | 22.48 | 7.45 | 16.71 | 28.24 | 331.55 |
| Feb 14, 2017 | 40.99 | 10.49 | 12.64 | 21.37 | 5.23 | 28.70 | 25.13 | 2,143.58 |
| Mar 2, 2016 | 37.71 | 11.61 | 13.07 | 17.27 | 5.50 | 30.74 | 22.15 | — |
| Feb 18, 2015 | 55.49 | 28.64 | 19.13 | 17.94 | 10.19 | 49.17 | 20.63 | — |
| Feb 18, 2014 | 162.89 | 14.31 | 16.19 | 16.24 | 28.54 | 42.99 | 30.40 | — |
| Feb 15, 2013 | 30.11 | 10.44 | 12.22 | 13.40 | 16.28 | 35.11 | 17.92 | 4,319.80 |
| Feb 24, 2012 | 31.41 | — | 12.48 | 14.04 | 9.02 | — | 16.64 | 69.48 |
| Feb 28, 2011 | 41.85 | — | 8.79 | 15.14 | 7.82 | — | 17.09 | — |
| Feb 26, 2010 | 34.79 | — | 10.12 | 15.63 | 12.16 | — | 19.04 | — |
| Feb 26, 2009 | 48.40 | — | 9.70 | 8.85 | 15.24 | — | 12.33 | — |
| Feb 26, 2008 | — | — | 12.44 | 13.65 | 18.80 | — | 24.03 | — |
| Feb 28, 2007 | 53.36 | — | 19.54 | 14.52 | — | — | 79.09 | — |
| Mar 6, 2006 | — | — | 17.96 | 15.18 | 25.01 | — | 21.48 | — |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).